On Friday, Dyne Therapeutics Inc (NASDAQ: DYN) was 3.45% up from the session before settling in for the closing price of $21.17. A 52-week range for DYN has been $6.36 – $31.32.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -59.45%. When this article was written, the company’s average yearly earnings per share was at -5.21%. With a float of $104.93 million, this company’s outstanding shares have now reached $142.61 million.
Dyne Therapeutics Inc (DYN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dyne Therapeutics Inc stocks. The insider ownership of Dyne Therapeutics Inc is 26.53%, while institutional ownership is 83.58%. The most recent insider transaction that took place on Sep 05 ’25, was worth 35,402. In this transaction CEO & President of this company sold 2,640 shares at a rate of $13.41, taking the stock ownership to the 199,539 shares. Before that another transaction happened on Sep 04 ’25, when Company’s Chief Commercial Officer sold 894 for $13.27, making the entire transaction worth $11,863. This insider now owns 95,017 shares in total.
Dyne Therapeutics Inc (DYN) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.88 earnings per share (EPS) during the time that was better than consensus figure (set at -0.91) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.85 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.71% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
You can see what Dyne Therapeutics Inc (DYN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.47. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.66, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -3.37 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
The latest stats from [Dyne Therapeutics Inc, DYN] show that its last 5-days average volume of 2.4 million was inferior to 2.63 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 77.98%.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 81.50%, which indicates a significant decrease from 90.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.50 in the past 14 days, which was higher than the 0.93 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.57, while its 200-day Moving Average is $12.95. Now, the first resistance to watch is $22.60. This is followed by the second major resistance level at $23.29. The third major resistance level sits at $24.30. If the price goes on to break the first support level at $20.90, it is likely to go to the next support level at $19.89. Assuming the price breaks the second support level, the third support level stands at $19.20.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are 142,825K outstanding shares of the company, which has a market capitalization of 3.13 billion. As of now, sales total 0 K while income totals -317,420 K. Its latest quarter income was 0 K while its last quarter net income were -108,040 K.
